| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,344 | 11,455 | 11,385 | 11,634 | | Cost of Revenue | 2,572 | 2,940 | 3,358 | 4,060 | | | Gross Profit |
-
| 8,515 | 8,027 | 7,574 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,043 | 5,258 | 5,682 | 4,742 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,714 | 868 | 12,680 | 1,535 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,389 | (10,335) | 1,297 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,015 | 2,389 | (10,335) | 1,297 | | Interest Expense | 895 | 1,026 | 1,096 | 1,174 | | Income Before Tax | 120 | 1,363 | (11,431) | 123 | | Income Tax Expense | 51 | 563 | (4,702) | 62 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 69 | 800 | (6,729) | 61 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 69 | 800 | (6,729) | 61 | | Preferred Stock And Other Adjustments | (784) | 261 | (261) | (35) | | | Net Income Applicable To Common Shares | ($715) | $1,061 | ($6,990) | $26 |
|
0.02% Nasdaq 0.00%
Income Statement
